To improve childhood health through partnerships with health authorities and professionals, Sanofi has launched across the African continent the Paediatrics Initiative entitled â€œHealthy Children, Happy Children.â€
In line with the launch, Sanofi Paediatric Initiative weekend in Lagos commissioned Paediatric Fun Centre at the Lagos University Teaching Hospitalâ€™s (LUTH) Paediatric Ward as its 1st Paediatrics Initiative in Nigeria.
The Fun centre which also gave a facelift to the childrenâ€™s ward of the hospital was part of the companyâ€™s determination to diversify and adapt its healthcare offer to young Nigerians and African patients at large.
Speaking at the commissioning of the Centre, the Chief Medical Director of the Hospital, Professor Akin Osibogun, who stressed the importance of social health, noted that the environment where a child is kept also contributes a lot to the health of the child.
Thanking Sanofi for coming from the rubbles to put a smile on the faces of the children and those yet unborn, Osibogun said the company has written their name in Gold as it concerns childrenâ€™s health.
Represented by the Director of Administration, Mr. Ayo Olagunju, he pledged to ensure that the fun centre is maintained at all times.
On his part, Head of Paediatric, LUTH, Professor A. O AKINSULIE also noted the importance of the environment to childrenâ€™s health. He commended the company for all their efforts at making the project a success.
Presenting Sanofi Paediatric Initiative in Africa to the gathering, Medical and Regulatory Director, SANOFI North East Africa, Dr. Fifen Inoussa noted that with 42 percent of the total population of Africans under than 15 years old, paediatrics should be key priority.
Noting that not less than 4 million children die in Africa annually, Inoussa stated that Sanofiâ€™s paediatric Initiative has been designed into three pillars to tackle the problems.
He explained that the first concerns which was the development of medicines and vaccines offer,adding that the company will broaden its offer to new therapeutic areas, develop formulations and dosages adjusted to the needs of African patients, and improve access to medicine.